RNF168 Antibodies

Santa Cruz Biotechnology provides a broad selection of RNF168 monoclonal antibodies for research focused on understanding RNF168's role in cellular processes. RNF168 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RNF168 functions as an E3 ubiquitin ligase with significant involvement in the DNA damage response, particularly in repairing double-strand breaks. Through ubiquitination of target proteins, RNF168 regulates the recruitment of repair factors to damage sites, maintaining genomic stability. Understanding RNF168's role in cancer biology and therapeutic resistance continues to drive research in tumorigenesis and treatment responses. RNF168 monoclonal antibodies enable precise detection and analysis of protein expression, localization, and interactions. Researchers can utilize RNF168 monoclonal antibodies to explore protein function in various cellular pathways and mechanisms. Advanced research techniques supported by RNF168 monoclonal antibodies help unlock new insights into cellular regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and potential therapeutic applications.